Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
复制标题
支持在康复住所使用阿片类药物使用障碍药物的个人：解决阿片类药物流行病的挑战和机遇。
DOI：
10.1080/00952990.2020.1719410
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Mericle,Amy
中科院分区：
文献类型：
--
作者：
Miles,Jennifer;Howell,Jason;Sheridan,Dave;Braucht,George;Mericle,Amy
完全和部分阿片类激动剂和阿片类拮抗剂药物在遏制阿片类药物流行方面发挥着重要作用。然而，这些药物并没有被充分利用。恢复支助服务，如恢复住所，也发挥着关键作用。RRs可以增加个人的恢复资本，促进社会对禁欲的支持，并在居民中培养社区意识。这些过程可能对阿片类药物使用障碍（OUD）患者至关重要。结合这两种恢复途径有可能相互促进，并改善OUD居民的结果。这样做的障碍导致住宅供应有限，可以支持居民使用阿片类激动剂和拮抗剂药物。这种观点描述了关键的人际和结构性障碍，以寻求支持，从恢复住宅的OUD个人之间的药物使用，并讨论了减少这些障碍的措施。这些措施包括发展劳动力，以解决污名化和态度障碍，并提高居住能力，以确保居民安全和减少潜在的转移。该观点还强调需要进行更多的研究，以促进确定最佳做法，以改善居住在康复住宅中接受药物治疗的居民的结果。
Full and partial opioid agonists and opioid antagonist medications play an important role in containing the opioid epidemic. However, these medications have not been used to their full extent. Recovery support services, such as recovery residences (RRs), also play a key role. RRs may increase an individual’s recovery capital, facilitate social support for abstinence, and foster a sense of community among residents. These processes may be critical for individuals with opioid use disorder (OUD). In combination these two recovery pathways have the potential to enhance one another and improve outcomes among residents with OUD. Barriers to doing so have resulted in a limited supply of residences that can support residents using opioid agonist and antagonist medications. This perspective describes key interpersonal and structural barriers to medication use among individuals with an OUD seeking support from a recovery residence and discusses measures for reducing these barriers. These measures include workforce development to address stigma and attitudinal barriers and enhancing residence capability to ensure resident safety and reduce potential diversion. The perspective also highlights the need for additional research to facilitate the identification of best practices to improve outcomes among residents treated with medications living in recovery residences.